Stem Cell Stocks 4/26/09: The Week That Was

There has still been no signifcant action with the stem cell stocks. Cancer drugs were hot last week. This week, it's all about the swine flu. As a result, I don't anticipate much upward movement with these stocks this week.

Top Stem Cell Stock Performer(s) for Last Week:

- BioTime, Inc. (BTIM) = Up 25% for the week; This stock rose on word that Broadwood Partners, which is already one of BTIM's large share holders, purchased around 35,000 additional shares.

Worst Stem Cell Stock Performer(s) for Last Week:

- Geron Corp (GERN) = Down -9% for the week; No signicant news; The stock had been on a good run the past few weeks. This just looks like profit taking.

Stem Cell Stocks Current Price and % Up or Down 4/20/09 - 4/24/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Cur Price: $1.52; Up 3%
Aastrom Biosciences (ASTM) = Cur Price: $0.326; Down -8%
BioTime, Inc. (BTIM) = Cur Price: $2.17; Up 24%
Celgene Corp (CELG) = Cur Price: $39.86; Up 4%
Cytori Therapeutics (CYTX) = Cur Price: $1.79; Down -1%
Geron Corp (GERN) = Cur Price: $4.94; Down -9%
ThermoGenesis (KOOL) = Cur Price: $0.59; Down -4%
Osiris Therapeutics (OSIR) = Cur Price: $12.34; Down -4%
StemCell Inc. (STEM) = Cur Price: $1.62; Down -4%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Cur Price: $0.0995; Unchanged
Athersys Inc. (ATHX) = Cur Price: $0.80; Down -1%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.08; Unchanged
Bioheart Inc. (BHRT) = Cur Price: $0.69; Unchanged
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0057; Down -4%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $0.80; Up 14%
Neuralstem (CUR) = Cur Price: $1.18; Down -2%
International Stem Cell (ISCO.OB) = Cur Price: $0.525; Up 22%
LifeStem International (LSTM.OB) = Cur Price: $0.008; Down -11%
MultiCell Technologies (MCET.OB) = Cur Price: $0.01; Down -5%
Pluristem Therapeutics (PSTI) = Cur Price: $1.33; Unchanged
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.095; Down -5%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.041; Up 3%

Catalyst(s) for the Week:

The catalyst(s) for the week remain unchanged from last week.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- More Mutual fund distribution of funds originally allocated for Genentech. It will take quite a while to redistribute these dollars throughout the biotech sector

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Stem Cell Stocks 4/19/09: The Week That Was

Once again nothing definitive this week for the stem cell stocks. Most the the larger cap stock were up, but most of the smaller cap stocks fell for the week. I am really not expecting much from the stem cells stocks in the very near future. With the news from Dendreon last week, cancer related biotech stocks have become the new hot play. Unless some fresh big news develops in the stem cell space, look for the current trading action to continue.


Top Stem Cell Stock Performer(s) for Last Week:

- ThermoGenesis (KOOL) = Up 19% for the week; The only real news this week was that they appointed a new CEO; I don't think that is enough to maintain this momentum

Worst Stem Cell Stock Performer(s) for Last Week:

- International Stem Cell Corp (ISCO.OB) = Down -14% for the week; No news; A couple of weeks ago this had one of the best charts in the sector. It has significantly brokend down since then

Stem Cell Stocks Current Price and % Up or Down 4/13/09 - 4/17/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Current Price: $1.48; Up 3%
Aastrom Biosciences (ASTM) = Current Price: $0.354; Up 4%
BioTime, Inc. (BTIM) = Current Price: $1.75; Down -9%
Celgene Corp (CELG) = Current Price: $38.30; Down -6%
Cytori Therapeutics (CYTX) = Current Price: $1.81; Up 5%
Geron Corp (GERN) = Current Price: $5.40; Up 10%
ThermoGenesis (KOOL) = Current Price: $0.615; Up 19%
Osiris Therapeutics (OSIR) = Current Price: $12.82; Up 3%
StemCell Inc. (STEM) = Current Price: $1.69; Up 8%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Current Price: $0.0995; Up 2%
Athersys Inc. (ATHX) = Current Price: $0.81; Down -4%
Brainstorm Cell Therapeutics (BCLI.OB) = Current Price: $0.08; Down -10%
Bioheart Inc. (BHRT) = Current Price: Current Price: $0.69; Up 1%
Cord Blood America Inc. (CBAI.OB) = Current Price: $0.0057; Unchanged
Cyro-Cell Intl (CCEL.OB) = Current Price: $0.70; Unchanged
Neuralstem (CUR) = Current Price: $1.20; Down -2%
International Stem Cell (ISCO.OB) = CurrentPrice: $0.43; Down -14%
LifeStem International (LSTM.OB) = Current Price: $0.009; Down -2%
MultiCell Technologies (MCET.OB) = Current Price: $0.0105; Down -10%
Pluristem Therapeutics (PSTI) = Current Price: $1.33; Up 8%
Stem Cell Therapy Intl (SCII.OB) = Current Price: $0.10; Unchanged
Stem Cell Innovations (SCLL.PK) = Current Price: $0.04; Down -13%

Catalyst(s) for the Week:

The catalyst(s) for the week remain unchanged from last week.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- More Mutual fund distribution of funds originally allocated for Genentech. It will take quite a while to redistribute these dollars throughout the biotech sector

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

While the stem cell stocks lag, don't forget to check out my other blog http://yourtradingtips.blogspot.com which provides some insight on ways to make some quick money in the stock market.

Stem Cell Stocks 4/11/09: The Week That Was

The stem cell stocks were a mixed bag this week. They still seem to be in search of that key news to put the sector back in the spotlight. Overall, the stock market was flat during the week and the stem cell stocks seemed to follow suit. However, I have noticed over the past few weeks that those stem cell stocks that have reported quarterly earnings have responded positively (albeit temporarily).

Top Stem Cell Stock Performer(s) for Last Week:

- Cyro-Cell International (CCEL.OB) = Up 37% for the week; On 4/9/09 CCEL reported Qtr.1 2009 results; The most notable news was that the company stated that prospective clients were up 94% compared to the same period a year ago.



Worst Stem Cell Stock Performer(s) for Last Week:

- Stem Cell Therapy International Inc. (SCII.OB) = Down; -20% for the week; Last week this was the sector's top gainer; It looks like this is just classic profit taking


Stem Cell Stocks Current Price and % Up or Down 4/06/09 - 4/10/09


Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Current Price: $1.43; Up 6%
Aastrom Biosciences (ASTM) = Current Price: $0.34; Down -7%
BioTime, Inc. (BTIM) = Current Price: $1.93; Down -9%
Celgene Corp (CELG) = Current Price: $40.80; Down -3%
Cytori Therapeutics (CYTX) = Current Price: $1.72; Down -5%
Geron Corp (GERN) = Current Price: $4.92; Up 9%
ThermoGenesis (KOOL) = Current Price: $0.518; Down -9%
Osiris Therapeutics (OSIR) = Current Price: $12.42; Down -9%
StemCell Inc. (STEM) = Current Price: $1.57; Down -5%

Market Cap Under 50 Million


Advanced Cell Technology (ACTC.OB) = Current Price: $0.098; Down -7%
Athersys Inc. (ATHX) = Current Price: $0.84; Up 5%
Brainstorm Cell Therapeutics (BCLI.OB) = Current Price: $0.089; Up 5%
Bioheart Inc. (BHRT) = Current Price: Current Price: $0.68; Up 24%
Cord Blood America Inc. (CBAI.OB) = Current Price: $0.0057; Down -14%
Cyro-Cell Intl (CCEL.OB) = Current Price: $0.70; Up 37%
Neuralstem (CUR) = Current Price: $1.23; Down -3%
International Stem Cell (ISCO.OB) = CurrentPrice: $0.50; Up 2%
LifeStem International (LSTM.OB) = Current Price: $0.0092; Down -8%
MultiCell Technologies (MCET.OB) = Current Price: $0.0117; Down -6%
Pluristem Therapeutics (PSTI) = Current Price: $1.23; Down -1%
Stem Cell Therapy Intl (SCII.OB) = Current Price: $0.10; Down -20%
Stem Cell Innovations (SCLL.PK) = Current Price: $0.046; Down -8%

Catalyst(s) for the Week:

The catalyst(s) for the week remain unchanged from last week.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- More Mutual fund distribution of funds originally allocated for Genentech. It will take quite a while to redistribute these dollars throughout the biotech sector

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Stem Cell Stocks 4/3/09: The Week That Was

This was another lackluster week for the stem cell stocks. Most of these stocks were slightly down, while once again, the overall market edged higher. In an incredible sign of market strength, the the Dow closed the week over 8000. The stem cell stocks are still not participating in the rally.

Top Stem Cell Stock Performer(s) for Last Week:

- Stem Cell Therapy International Inc. (SCII.OB) = Up 67% for the week; Last week the company announced its first new product, a cosmetic face cream made with stem cells. The cream is said to rejuvenate the skin and provide excellent health for facial tissues. The market seemed to be impressed.

Worst Stem Cell Stock Performer(s) for Last Week

- Cord Blood America (CBAI.OB) = Down -23% for the week; After a brief rise, the stock appears to be under selling pressure after it was voted to allow management to increase the number authorized common shares.

Stem Cell Stocks Current Price and % Up or Down 3/30/09 - 4/03/09

Market Cap Over 50 Million

Ariad Pharmaceuticals (ARIA) = Current Price: $1.35; Down -1%
Aastrom Biosciences (ASTM) = Current Price: $0.365; Down -9%
BioTime, Inc. (BTIM) = Current Price: $2.11; Unchanged
Celgene Corp (CELG) = Current Price: $42.15; Down -8%
Cytori Therapeutics (CYTX) = Current Price: $1.81; Up 1%
Geron Corp (GERN) = Current Price: $4.51; Down -8%
ThermoGenesis (KOOL) = Current Price: $0.57; Down -5%
Osiris Therapeutics (OSIR) = Current Price: $13.66; Down -5%
StemCell Inc. (STEM) = Current Price: $1.66; Down -8%

Market Cap Under 50 Million

Advanced Cell Technology (ACTC.OB) = Current Price: $0.105; Down -16%
Athersys Inc. (ATHX) = Current Price: $0.80; Down -8%
Brainstorm Cell Therapeutics (BCLI.OB) = Current Price: $0.085; Down -8%
Bioheart Inc. (BHRT) = Current Price: Current Price: $0.55; Down -8%
Cord Blood America Inc. (CBAI.OB) = Current Price: $0.0066; Down -23%
Cyro-Cell Intl (CCEL.OB) = Current Price: $0.512; Down -17%
Neuralstem (CUR) = Current Price: $1.27; Up 20%
International Stem Cell (ISCO.OB) = CurrentPrice: $0.49; Down -2%
LifeStem International (LSTM.OB) = Current Price: $0.01; Up 33%
MultiCell Technologies (MCET.OB) = Current Price: $0.0125; Down -7%
Pluristem Therapeutics (PSTI) = Current Price: $1.24; Down -8%
Stem Cell Therapy Intl (SCII.OB) = Current Price: $0.125; Up 67%
Stem Cell Innovations (SCLL.PK) = Current Price: $0.005; Down -17%

Possible Catalyst(s) for the Week:

The catalyst(s) for the week remain unchanged from last week.

- Again, be on the lookout for further legislative movement to support President Obama's executive order.

- More Mutual fund distribution of funds originally allocated for Genentech. It will take quite a while to redistribute these dollars throughout the biotech sector.

- M&A (mergers and acquisitions) activity will be key. It could happen at any time.

Ending Thoughts:

The stem cell stocks definitely need to get moving in the next couple of weeks to maintain any level of relevancy. With the market bulling its way forward and so many other sectors recovering with such strength, these stocks are in desperate need of a charge.